BofA/Merrill Lynch Starts Seattle Genetics (SGEN) at Buy
Tweet Send to a FriendGet Alerts SGEN Hot Sheet
Price: $32.20 +0.69%
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade SGEN Now!
BofA/Merrill Lynch initiates coverage on Seattle Genetics (NASDAQ: SGEN) with a Buy.
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Shares of Seattle Genetics closed at $16.45 yesterday, with a 52 week range of $10.25-$18.05.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Shares of Seattle Genetics closed at $16.45 yesterday, with a 52 week range of $10.25-$18.05.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Global Equities Starts Tesla Motors (TSLA) at Overweight
- UPDATE: UBS Starts Insmed (INSM) at Buy
- Seattle Genetics (SGEN) Initiates ADCETRIS Phase 1/2
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
